title: Aprepitant for paediatric chemotherapy-induced nausea and vomiting - Authors' reply.
authors.affiliation: Merck, Kenilworth, NJ, USA. Electronic address: stuart.green@merck.com.
authors.forename: Stuart
authors.initials: S
authors.lastname: Green
authors.affiliation: Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands.
authors.forename: Christian Michel
authors.initials: CM
authors.lastname: Zwaan
authors.affiliation: Department of Pediatrics, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University Children's Hospital, Seoul, South Korea.
authors.forename: Hyoung Jin
authors.initials: HJ
authors.lastname: Kang
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D009025:Morpholines / Q000008:administration & dosage*; D009325:Nausea / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000188:drug therapy*
chemical_list: D009025:Morpholines